drugset / Trial / NCT00084838

Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT

NCT00084838 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Giving more than one chemotherapy drug with radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving intrathecal and systemic combination chemotherapy together with radiation therapy works in treating young patients with newly diagnosed central nervous system (CNS) atypical teratoid/rhabdoid tumors.

Timeline

Start
2003-02
Primary completion
2008-02
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — Intravenous
Subject Cyclophosphamide Other / unclassified — Intravenous
Subject Cytarabine Small molecule — Intrathecal
Subject Dactinomycin Unknown — Intravenous
Subject Doxorubicin Other / unclassified — Intravenous
Subject Etoposide Small molecule — Intravenous
Subject Methotrexate Small molecule — Intrathecal
Subject Temozolomide Small molecule — Oral
Subject Vincristine Small molecule — Intravenous
Background Dexrazoxane Small molecule — Intravenous
Background Leucovorin Small molecule — Oral
Background filgrastim Protein / enzyme biologic — Subcutaneous
Background therapeutic hydrocortisone Unknown — Intrathecal